Trials for the vaccine, which International Vaccine Institute is developing in partnership with Bharat Biotech, are also expected to begin in Panama and Colombia by September.
Bharat Biotech CMD Dr Krishna Ella said final phase of clinical trial is over & they hope to get licence soon. NIV Director Dr Priya Abraham said vaccines may be available by Sept.
BBV154 is the first of its kind Covid-19 jab to undergo human clinical trials in India which is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine.
The statement from Hyderabad-based Covid vaccine manufacturer comes after reports surfaced claiming that Covaxin's test batches from the Bengaluru plant were not satisfactory.
The approval came from the National Institute of Pharmacy and Nutrition Hungary and it marks the first compliance certificate received by Bharat Biotech from European regulators.
Brazil's decision came after Bharat Biotech terminated its pact with the country after its deal to supply 20 million Covaxin doses attracted investigation by Brazilian authorities.
The Jair Bolsonaro-led Brazil government cancelled Indian drugmaker Bharat Biotech’s emergency use authorisation request for its Covaxin vaccine on 24 July.
The termination came after the deal with the Brazilian Government for the supply of 20 million doses of the Covaxin landed in controversy and attracted investigation by authorities.
From January to 16 July, 54.5 million doses of Covaxin have been supplied to the government, MoS Health Bharati Pravin Pawar said in Parliament, earlier this week.
Suchitra Ella of Bharat Biotech said approval is not expected to be a long process as majority of Bharat Biotech's facilities have been audited and approved by WHO in the past.
The IndiGo crisis is nothing short of a threat to India’s stability. Could it be an experiment? Can this happen in any other crucial sector like power or railways?
RBI Handbook of Statistics shows state’s GSDP has more than doubled in past decade, finishing second behind Maharashtra. It has performed well across health & education parameters as well.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS